Company profile
Takeda Pharmaceutical Company Limited
Pipeline15 assets
- RelugolixTAK-385
- BrigatinibAlunbrig
- IxazomibNinlaro
- FruquintinibFruzaqla
- RusfertideTAK-121
- ElriterceptTAK-226
Latest news0 items
All newsNo recent headlines yet.
New company coverage will appear here as soon as it is picked up.